RADT-25. EVALUATING LYMPHOCYTE COUNTS IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING CHEMORADIATION

BACKGROUND: Glioblastoma (GBM) patients are treated with chemotherapy, radiation therapy (RT) and often corticosteroids, which can all contribute to lymphopenia. We examined lymphopenia with respect to incidence, predictors, and association with progression-free survival (PFS) and overall survival (...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Hammoudeh, Lubna, Lim-Fat, Mary Jane, Cagney, Daniel, Aizer, Ayal A, Tanguturi, Shyam, Arvold, Nils, Mcfaline-Figueroa, Jose, Chukwueke, Ugonma, Reardon, David, Lee, Eudocia, Nayak, Lakshmi, Rinne, Mikael, Ligon, Keith, Wen, Patrick, Alexander, Brian, Rahman, Rifaquat
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Clinical Radiotherapy
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651411/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.778
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares